Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Olivier Michielin MD, PhD

Prof. Olivier Michielin MD, PhD

Head, Department of Oncology and Precision Oncology Service, Geneva University Hospital, Geneva, Switzerland; Co-Director, Swiss Cancer Center Léman (SCCL), Agora-Lausanne; Group Leader, Swiss Institute of Bioinformatics, Lausanne, Switzerland

Prof. Olivier Michielin obtained a Masters of Physics in 1991 at the Swiss Federal Institute of Technology and a Medical Degree from the University of Lausanne in 1997. He pursued his PhD training under the supervision of Jean-Charles Cerottini (Ludwig Institute) and Martin Karplus (Harvard and Strasbourg Universities, Chemistry Nobel Prize Laureate 2013). He was appointed Group Leader of the Swiss Institute of Bioinformatics in 2002 and became an Assistant Professor at the Medical Faculty of Lausanne in 2004. In parallel, he has trained as a medical oncologist and obtained his board certification in 2007 at the Department of oncology of the Lausanne University Hospital. Prof. Olivier Michielin is mainly focused on translational and precision oncology, developing new molecularly defined therapeutic approaches based on original bioinformatics techniques developed in his laboratory, as well as precision oncology programs based on multi-omics strategies and data science at the national level. Prof. Olivier Michielin is currently the Chair of the Department of Oncology and the Precision Oncology Service at the Geneva University Hospital, and the co-Director of the Swiss Cancer Center Léman (SCCL).